David C. Dale
#109,459
Most Influential Person Now
Researcher
David C. Dale's AcademicInfluence.com Rankings
David C. Dalecomputer-science Degrees
Computer Science
#4088
World Rank
#4304
Historical Rank
Artificial Intelligence
#901
World Rank
#918
Historical Rank
Database
#1324
World Rank
#1396
Historical Rank
Download Badge
Computer Science
David C. Dale's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is David C. Dale Influential?
(Suggest an Edit or Addition)David C. Dale's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- THE HYPEREOSINOPHILIC SYNDROME: Analysis of Fourteen Cases With Review of The Literature (1975) (1348)
- Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist (2005) (1130)
- Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients (2006) (1001)
- Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. (2003) (750)
- The phagocytes: neutrophils and monocytes. (2008) (676)
- Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. (2007) (652)
- Chemotherapy‐induced neutropenia (2004) (597)
- Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. (2000) (521)
- Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis (1999) (450)
- A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. (1993) (432)
- Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices. (2003) (426)
- The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. (2005) (397)
- Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. (1989) (348)
- Severe chronic neutropenia: Treatment and follow‐up of patients in the Severe Chronic Neutropenia International Registry (2003) (338)
- The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. (1993) (323)
- Glucocorticoids inhibit apoptosis of human neutrophils. (1995) (322)
- Colchicine therapy for familial mediterranean fever. A double-blind trial. (1974) (318)
- The hypereosinophilic syndrome (1975) (303)
- Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study. (2004) (295)
- Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models. (1998) (267)
- Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics (2014) (266)
- Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. (1996) (265)
- Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte–colony‐stimulating factor by single‐dose administration of AMD3100, a CXCR4 antagonist (2005) (240)
- Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases. (1995) (235)
- Risk of Febrile Neutropenia among Patients with Intermediate-grade non-Hodgkin's Lymphoma Receiving CHOP Chemotherapy (2003) (231)
- Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. (2000) (220)
- Cyclic neutropenia: a clinical review. (1988) (213)
- Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice. (2008) (211)
- Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. (2000) (209)
- Granulocyte colony-stimulating factor and granulocyte-macrophage colony- stimulating factor (1999) (209)
- Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy (2011) (209)
- Stable long‐term risk of leukaemia in patients with severe congenital neutropenia maintained on G‐CSF therapy (2010) (205)
- A Randomized Controlled Trial of Filgrastim as an Adjunct to Antibiotics for Treatment of Hospitalized Patients with Community-Acquired Pneumonia (1998) (204)
- Long‐term safety of treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) in patients with severe congenital neutropenias (1994) (193)
- Colony-Stimulating Factors for the Management of Neutropenia in Cancer Patients (2002) (190)
- Lineage-specific hematopoietic growth factors. (2006) (187)
- Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. (2006) (186)
- Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. (1994) (185)
- CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease. (2015) (180)
- Human Cyclic Neutropenia: Clinical Review and Long-Term Follow-up of Patients (1981) (173)
- Evaluation and management of patients with isolated neutropenia. (2013) (159)
- Achieving a High-Performance Health Care System with Universal Access: What the United States Can Learn from Other Countries (2008) (158)
- Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review. (2010) (157)
- Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. (2002) (155)
- Severe congenital neutropenias (2017) (154)
- Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. (2000) (149)
- Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia (2009) (148)
- Periodic hematopoiesis in human cyclic neutropenia. (1973) (147)
- Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy (2006) (141)
- Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients. (1999) (141)
- The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report. (2006) (141)
- Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens. (2007) (135)
- Corticosteroids and infectious diseases. (1973) (132)
- Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy (2007) (132)
- Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. (1997) (129)
- Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. (2013) (127)
- Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. (2007) (126)
- Pathophysiology and treatment of severe chronic neutropenia (1996) (121)
- Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry. (2014) (121)
- A comparative trial of granulocyte‐colony‐stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers (1997) (120)
- Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors (2002) (119)
- Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3. (1993) (118)
- Pseudomonas aeruginosa infections: persisting problems and current research to find new therapies. (1975) (118)
- Neutropenia: causes and consequences. (2002) (116)
- Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte‐colony‐stimulating factor and dexamethasone (1998) (115)
- The diversity of mutations and clinical outcomes for ELANE-associated neutropenia (2015) (107)
- Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. (2000) (106)
- Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. (1991) (106)
- Management of kostmann syndrome in the g‐csf era (2000) (104)
- Transplantation of Allogeneic Bone Marrow in Canine Cyclic Neutropenia (1974) (101)
- The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome. (2011) (100)
- Cyclic hematopoiesis: the mechanism of cyclic neutropenia in grey collie dogs. (1972) (100)
- Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist. (2004) (100)
- Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. (1999) (99)
- Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized clinical trials. (2003) (97)
- Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever. (1975) (97)
- Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia (2007) (97)
- Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. (2007) (92)
- Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. (1976) (90)
- Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis. (1996) (89)
- Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia. (2001) (88)
- Crawford J, Dale DC, Lyman GH. Chemotherapy‐induced neutropenia: risks, consequences, and new directions for its management. Cancer. (2004) 100(2):228–37. (2004) (88)
- Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases. (2001) (88)
- Occurrence of periodic oscillations in the differential blood counts of congenital, idiopathic, and cyclical neutropenic patients before and during treatment with G-CSF. (1999) (87)
- Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. (2004) (87)
- Neutrophil-endothelial cell interactions on endothelial monolayers grown on micropore filters. (1981) (85)
- Poor prognosis in elderly patients with cancer: the role of bias and undertreatment. (2003) (85)
- Effects of granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) on neutrophil kinetics and function in normal human volunteers (1998) (84)
- Chronic neutropenia. (1979) (84)
- Somatic mutations and clonal hematopoiesis in congenital neutropenia. (2018) (83)
- Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study (2014) (80)
- The many causes of severe congenital neutropenia. (2009) (77)
- Inherited Neutrophil Disorders: Molecular Basis and New Therapies. (2000) (76)
- A Pharmacokinetic‐pharmacodynamic Model for the Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100 (2005) (76)
- Modeling complex neutrophil dynamics in the grey collie. (2000) (74)
- Cyclic Urinary Leukopoietic Activity in Gray Collie Dogs (1971) (74)
- Severe congenital neutropenia. (2006) (72)
- Studies of neutrophil production and turnover in grey collie dogs with cyclic neutropenia. (1972) (72)
- Granulocyte transfusion therapy of experimental Pseudomonas pneumonia. (1974) (72)
- Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer. (2013) (69)
- A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group. (1998) (67)
- Myeloid growth factors clinical practice guidelines in oncology. (2005) (65)
- Gene therapy for long-term expression of erythropoietin in rats. (1995) (62)
- Cyclic and chronic neutropenia. (2011) (62)
- How I manage children with neutropenia (2017) (61)
- Studies of the neutropenia of acute malaria. (1973) (61)
- Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome (2021) (60)
- Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. (2003) (59)
- Hematopoietic progenitors in cyclic neutropenia: effect of granulocyte colony-stimulating factor in vivo. (1990) (57)
- Preparing for a consumer-driven genomic age. (2010) (57)
- Combined administration of G–CSF and dexamethasone for the mobilization of granulocytes in normal donors: optimization of dosing (2000) (55)
- Aging and Marrow Neutrophil Reserves (1994) (54)
- Colon ulceration and perforation in cyclic neutropenia. (1973) (54)
- Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: Evidence for phenotype determination by modifying genes (2010) (52)
- RENEWED INTEREST IN GRANULOCYTE TRANSFUSION THERAPY (1997) (51)
- Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden. (2006) (51)
- Aging and Haemopoiesis (1996) (51)
- Skin window studies of the acute inflammatory responses of neutropenic patients. (1971) (51)
- A systematic literature review of the efficacy, effectiveness, and safety of filgrastim (2017) (51)
- In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophil oxidative functions in normal human volunteers. (1997) (50)
- A comparison of treatment of canine cyclic hematopoiesis with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF interleukin-3, and canine G-CSF. (1990) (50)
- Correction of human cyclic neutropenia with prednisolone. (1978) (49)
- Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutations. (2006) (49)
- Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia. (2000) (49)
- Hematopoietic dynamics in grey collies. (1999) (48)
- Cyclic hematopoiesis: effects of lithium on colony-forming cells and colony-stimulating activity in grey collie dogs. (1982) (48)
- Deuterium and neutrophil kinetics. (2011) (48)
- Lactoferrin—Specific Localization in the Nuclei of Human Polymorphonuclear Neutrophilic Leukocytes (1971) (47)
- Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. (2001) (47)
- Neutrophil preservation: the effect of short-term storage on in vivo kinetics. (1977) (47)
- Eosinophil kinetics in the hypereosinophilic syndrome. (1976) (47)
- Experimental Pseudomonas pneumonia in leukopenic dogs: comparison of therapy with antibiotics and granulocyte transfusions. (1976) (43)
- Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy (2009) (43)
- Genetic and molecular diagnosis of severe congenital neutropenia (2009) (43)
- The rate of apoptosis in post mitotic neutrophil precursors of normal and neutropenic humans (2003) (43)
- Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases. (1994) (43)
- Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of colllection method, donor corticosteroid treatment, and short-term storage. (1979) (42)
- Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally transduced smooth muscle cells: a model for local and systemic gene therapy. (1994) (41)
- Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo. (1999) (41)
- An update on the diagnosis and treatment of chronic idiopathic neutropenia (2017) (41)
- Phase I study of a humanized anti‐CD11/CD18 monoclonal antibody in multiple sclerosis (1998) (40)
- The cost effectiveness of therapeutic and prophylactic leukocyte transfusion. (1980) (40)
- Lithium therapy of canine cyclic hematopoiesis. (1980) (40)
- A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative setting (2013) (40)
- Immune and idiopathic neutropenia (1998) (38)
- Application of Time Series Analysis to Serial Blood Neutrophil Counts in Normal Individuals and Patients Receiving Cyclophosphamide (1973) (37)
- Eosinophilic leukemia. Remission with vincristine and hydroxyurea. (1975) (37)
- First Cycle Risk of Severe and Febrile Neutropenia in Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Study. (2004) (36)
- Use of Granulocyte Colony-Stimulating Factor During Pregnancy in Women With Chronic Neutropenia (2015) (35)
- Kinetics of tumor-induced murine neutrophilia. (1979) (35)
- Current management of chemotherapy-induced neutropenia: the role of colony-stimulating factors. (2003) (35)
- How I diagnose and treat neutropenia (2016) (35)
- Meta-analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) in cancer patients receiving chemotherapy (2005) (35)
- Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy. (2005) (34)
- Abnormal responsiveness of granulocyte-committed progenitor cells in cyclic neutropenia. (1992) (34)
- Cyclic neutropenia. (2002) (34)
- ELANE-Related Neutropenia (2011) (33)
- Effect of endotoxin on serum granulocyte and granulocyte-macrophage colony-stimulating factor levels in dogs. (1992) (33)
- Cyclic and chronic neutropenia: an update on diagnosis and treatment. (2011) (33)
- Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte–colony‐stimulating factor (2005) (33)
- Myeloid growth factors. (2009) (32)
- Myeloid growth factors. Clinical practice guidelines in oncology. (2007) (32)
- TCIRG1‐Associated Congenital Neutropenia (2014) (31)
- Understanding, Treating and Avoiding Hematological Disease: Better Medicine Through Mathematics? (2015) (30)
- Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia. (2017) (29)
- Neutrophil transfusion: effect of storage and of collection method of neutrophil blood kinetics. (1978) (29)
- Advances in the treatment of neutropenia (2009) (28)
- Human cyclic neutropenia: urinary colony-stimulating factor and erythropoietin levels. (1974) (28)
- Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor (2019) (28)
- Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors. (1996) (28)
- Hematopoietic growth factors for the treatment of severe chronic neutropenia (1995) (28)
- Hematopoiesis in the grey collie dog: studies of the regulation of erythropoiesis. (1974) (27)
- Granulocyte transfusion therapy: update on potential clinical applications (2001) (27)
- Results of a Phase 2 Trial of an Oral CXCR4 Antagonist Mavorixafor for Treatment of WHIM Syndrome. (2020) (27)
- Variable Clinical Presentation of Shwachman-Diamond Syndrome: Update From the North-American Shwachman-Diamond Syndrome Registry. (2012) (27)
- The cellular and molecular mechanisms for neutropenia in Barth syndrome (2012) (26)
- Neutropenia in Barth syndrome: characteristics, risks, and management (2019) (26)
- Mutant elastase in pathogenesis of cyclic and severe congenital neutropenia. (2002) (25)
- Chronic thrombocytopenia is induced in dogs by development of cross-reacting antibodies to the MpL ligand. (1997) (25)
- Non-malignant neutropenia. (1996) (25)
- Blood phagocyte luminescence: gauging systemic immune activation. (2000) (24)
- Analysis of Factors Associated With In‐hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia (2017) (24)
- Neutrophil kinetics in chronic neutropenia. (1979) (23)
- Lithium therapy of canine cyclic hematopoiesis (1980) (23)
- CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients (2019) (23)
- Cyclic neutropenia: natural history and effects of long-term treatment with recombinant human granulocyte colony-stimulating factor. (1993) (22)
- Return of granulocyte transfusions. (2000) (22)
- Comparison of Demographic Characteristics, Surgical Resection Patterns, and Survival Outcomes for Veterans and Nonveterans with Non-small Cell Lung Cancer in the Pacific Northwest (2011) (21)
- Neutropenia, inflammation, and the kinetics of transfused neutrophils in rabbits. (1979) (21)
- Assessing patients’ risk of febrile neutropenia: is there a correlation between physician-assessed risk and model-predicted risk? (2015) (21)
- Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry. (2005) (21)
- Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies. (2013) (20)
- Elastase inhibitors as potential therapies for ELANE‐associated neutropenia (2017) (20)
- Therapeutic Use of Granulocyte Colony-Stimulating Factors for Established Febrile Neutropenia (2012) (20)
- Granulocyte transfusion therapy: a new era? (2009) (20)
- Cyclic hematopoiesis. Effects of endotoxin on colony-forming cells and colony-stimulating activity in grey collie dogs. (1979) (20)
- Distribution of granulocytopoietic committed stem cells in mice with tumor induced neutrophilia. (1980) (20)
- International forum: granulocyte transfusions. (2000) (20)
- The discovery, development and clinical applications of granulocyte colony-stimulating factor. (1998) (19)
- Infectious diseases : the clinician's guide to diagnosis, treatment, and prevention (2003) (19)
- The selective neutropenias. (1978) (19)
- Dose Intensity and Hematologic Toxicity in Older Cancer Patients Receiving Systemic Chemotherapy. (2005) (18)
- Defective polymorphonuclear leukocyte metabolism and function in canine cyclic neutropenia. (1975) (18)
- Long-term treatment of canine cyclic hematopoiesis with recombinant canine stem cell factor. (1995) (18)
- Clinical implications of mutations of neutrophil elastase in congenital and cyclic neutropenia. (2001) (18)
- Fever of undetermined origin (1982) (17)
- Molecular basis and therapy of disorders associated with chronic neutropenia (2003) (17)
- Heterozygous Variants of CLPB are a Cause of Severe Congenital Neutropenia. (2021) (17)
- Current Approach to the Management of Neutropenia (1995) (16)
- The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study (2015) (16)
- Restructuring an internal medicine residency program to meet regional and national needs for general internists. (1981) (16)
- Cyclic neutropenia in grey collie dogs. Ultrastructural evidence for abnormal neutrophil granulopoiesis. (1973) (15)
- Observations on the Pathophysiology and Mechanisms for Cyclic Neutropenia (2006) (15)
- Hematopoietic growth factors in oncology (2011) (15)
- Association Between Absolute Neutrophil Count and Variation at TCIRG1: The NHLBI Exome Sequencing Project (2016) (15)
- Experimental pneumonia due to Pseudomonas in dogs: controlled trial of granulocyte transfusion therapy. (1974) (14)
- How many neutrophils are enough? (1998) (14)
- Lithium augments GM-CSA generation in canine cyclic hematopoiesis. (1987) (14)
- Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy (2006) (14)
- Functional interaction between mutations in the granulocyte colony‐stimulating factor receptor in severe congenital neutropenia (2008) (14)
- Is There a Role for Anti-Neutrophil Antibody Testing in Predicting Spontaneous Resolution of Neutropenia in Young Children (2015) (14)
- Treatment of canine cyclic neutropenia by lentivirus-mediated G-CSF delivery. (2003) (13)
- Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor. (1993) (13)
- Stable Long-Term Risk of Leukemia in Patients with Severe Congenital Neutropenia Maintained On G-CSF Therapy. (2009) (13)
- Canine cyclic hematopoiesis: effects of chronic endotoxin administration (1978) (13)
- Suppression of in vitro granulocytopoiesis by captopril and penicillamine. (1988) (13)
- Lithium is an ineffective therapy for human cyclic hematopoiesis (1983) (12)
- Optimizing the management of chemotherapy-induced neutropenia. (2003) (12)
- Cyclic thrombocytopenia with statistically significant neutrophil oscillations (2018) (11)
- Long-term outcomes of myeloid growth factor treatment. (2011) (11)
- Analysis of cyclic neutropenia using digital band‐pass filtering techniques (1974) (11)
- Retraction. Neutrophil elastase mutations in severe congenital neutropenia patients of the original Kostmann family. (2003) (11)
- Canine cyclic hematopoiesis is associated with abnormal purine and pyrimidine metabolism. (1983) (11)
- Colony-stimulating factor in patients with chronic neutropenia. (1976) (11)
- Current Opinion in Hematology (2010) (11)
- Inhibition of in vivo neutrophil transmigration by a novel humanized anti-CD11/CD18 monoclonal antibody. (2000) (11)
- Colchicine therapy of familial Mediterranean fever. (1974) (11)
- Neutropenia Is an Underrecognized Finding in Pediatric Primary Immunodeficiency Diseases: An Analysis of the United States Immunodeficiency Network Registry (2020) (11)
- Emerging role of apoptosis in the pathogenesis of severe neutropenia (2000) (10)
- Outcomes of Pregnancies for Women with Severe Chronic Neutropenia with or without G-CSF Treatment. (2010) (10)
- The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects. (2015) (10)
- Economic analysis of pegfilgrastim in patients receiving cancer chemotherapy (2005) (10)
- Guidelines for pediatric management of severe chronic neutropenia (2012) (10)
- Cloxacillin chemoprophylaxis in the Chediak-Higashi syndrome. (1972) (10)
- Changing patterns of chemotherapy relative dose intensity and supportive care for aggressive B-cell non-Hodgkin lymphoma (2016) (10)
- An adult dog with cyclic neutropenia treated by lentivirus- mediated delivery of granulocyte colony-stimulating factor. (2006) (10)
- Changing Patterns of Chemotherapy Delivery and Supportive Care for Aggressive B-Cell Non-Hodgkin's Lymphoma (2011) (10)
- Defective polymorphonuclear leukocyte chemotaxis and bactericidal capacity in a boy with recurrent pyogenic infections. (1976) (9)
- Cost of Hospitalization in Patients with Cancer and Febrile Neutropenia and Impact of Comorbid Conditions (2015) (9)
- Neutrophils: Function and Role in Sepsis Syndrome (1998) (9)
- Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry. (2019) (9)
- Introduction to the hematopoietic growth factors. (2011) (8)
- Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpoint. (1997) (8)
- A risk model for first cycle febrile neutropenia in cancer patients receiving systemic chemotherapy (2005) (8)
- Use of G-CSF for granulocyte transfusion therapy. (2000) (8)
- Lithium is an ineffective therapy for human cyclic hematopoiesis. (1983) (7)
- Final Risk Prediction Model for Neutropenic Complications in Patients Receiving Cancer Chemotherapy (2008) (7)
- Neutrophil biology and the next generation of myeloid growth factors. (2009) (7)
- Autosomal dominant cyclic hematopoiesis: exclusion of linkage to the major hematopoietic regulatory gene cluster on chromosome 5 (1994) (6)
- Complications and costs associated with febrile neutropenia in hospitalized adult cancer patients (2004) (6)
- Granulocyte colony-stimulating factor in infectious diseases (1993) (6)
- Inherited Neutrophil Disorders (2000) (6)
- Distinct genetic pathways define pre-leukemic and compensatory clonal hematopoiesis in Shwachman-Diamond syndrome (2020) (6)
- Human cyclic hematopoiesis is associated with aberrant purine metabolism. (1985) (6)
- Cytokine treatment of bacterial pneumonia. (2001) (6)
- Serum Immunoglobulin Levels in Grey Collies (1971) (6)
- Understanding neutropenia. (2014) (6)
- Factors related to neutropenic events in early stage breast cancer patients (2008) (6)
- Cancer chemotherapy treatment patterns and febrile neutropenia in the US Veterans Health Administration. (2014) (5)
- Canine cyclic hematopoiesis: effects of chronic endotoxin administration. (1978) (5)
- Granulocyte (neutrophil) transfusion therapy (2003) (5)
- Canine cyclic haematopoiesis: the effect of endotoxin on erythropoiesis (1982) (5)
- The Risk of Low Bone Mineral Density with Long-Term G-CSF Therapy for Severe Chronic Neutropenia. (2010) (5)
- Issues in health services: edited by Stephen J. Williams, Wiley, New York, 1980. 371 pp. 116.95 (1981) (5)
- A comparative trial of granulocyte colony-stimulating factor (G-CSF) and dexamethasone alone and in combination for the mobilization of neutrophils in the peripheral blood of normal human volunteers (1996) (5)
- Antineutrophil Antibodies Lead to Mistaken Identity in Severe Congenital Neutropenia. (2005) (5)
- Cyclic Hematopoiesis in Gray Collie Dogs (1981) (5)
- Neutropenia in systemic lupus erythematosus (2004) (5)
- Lithium treatment of cyclic hematopoiesis in the gray collie. (1980) (5)
- Clinical use of hematopoietic growth factors. (1994) (5)
- A prediction model for chemotherapy-associated thrombocytopenia in cancer patients. (2006) (4)
- WebMD Scientific American, Medicine (2003) (4)
- Editorial: The mysteries of the spleen (2016) (4)
- Update On the Risk of Leukemia in Genetic Subgroups of Congenital Neutropenia (CN): Comparison of Patients with Known Gene Mutations (ELA2, HAX1, WASP, G6PC3, p14). (2009) (4)
- Introduction: severe chronic neutropenia. (2002) (4)
- Declining interest in internal medicine residencies: A crisis or a quirk? (1990) (4)
- A case of secondary acute myeloid leukemia on a background of glycogen storage disease with chronic neutropenia treated with granulocyte colony stimulating factor (2019) (4)
- Clinical Outcomes for Patients with Severe Chronic Neutropenia Due to Mutations in the Gene for Neutrophil Elastase, ELANE (2012) (4)
- A new look at an old laboratory test (1991) (4)
- Hematopoietic progenitors and aging (1993) (4)
- Termination and Frameshift Mutations in ELANE Are Associated with Adverse Outcomes in Patients with Severe Chronic Neutropenia (2016) (4)
- Recertification in internal medicine - the American experience. (2007) (4)
- Impact of pegfilgrastim on early all-cause mortality in patients receiving cancer chemotherapy (2008) (4)
- Economic analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) use based on a risk model for neutropenic complications in breast cancer patients receiving adjuvant chemotherapy. (2006) (4)
- RUNX1 Mutations Are the Most Frequent Leukemia Associated Mutations in Congenital Neutropenia Patients (2012) (4)
- Association of survival with chemotherapy intensity, myelosuppression, and supportive care in patients with advanced solid tumors. (2013) (3)
- IMPROVED SURVIVAL FROM GRANULOCYTE-COLONY STIMULATING FACTOR THERAPY FOR CONGENITAL NEUTROPENIA UNMASKS PREDISPOSITION TO MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA (1999) (3)
- Personalizing Cancer Supportive Care: Predicting Neutropenic Complications in Patients Receiving Intermediate Risk Cancer Chemotherapy (2011) (3)
- Risk and mortality associated with febrile neutropenia in lung cancer patients. (2004) (3)
- Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome (2008) (3)
- Impact of Comorbidities on Length of Stay and Mortality in Hospitalized Patients with Cancer and Febrile Neutropenia (2014) (3)
- Differential white blood cell count: underutilized or overrated. (2000) (3)
- X4P-001: A Novel Molecularly-Targeted Oral Therapy for Whim Syndrome (2017) (3)
- Neutrophils and the acute inflammatory response in chronic renal failure (1979) (3)
- Mechanism of canine cyclic hematopoiesis: The role of prostaglandin E in feedback regulation (1983) (3)
- Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. (1997) (3)
- A Conditional Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients. (2007) (3)
- Human cyclic neutropenia (1981) (3)
- Impact of G-CSF on Outcomes of Pregnancy in Women with Severe Chronic Neutropenia (2011) (3)
- Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor (2022) (3)
- Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome. (2019) (3)
- Complications and costs associated with febrile neutropenia in hospitalized adult cancer patients. (2004) (3)
- The effect of in vivo hydrocortisone (OHC) on in vitro lymphocyte function in humans (1973) (3)
- Declining interest in internal medicine residencies (1990) (3)
- Use of prophylactic pegfilgrastim for chemotherapy-induced neutropenia in the US: A review of adherence to present guidelines for usage. (2021) (3)
- Neutropenia and the Problem of Fever and Infection in Patients With Cancer (2004) (3)
- Pancreatic adenocarcinoma in two grey collie dogs with cyclic hematopoiesis. (1995) (3)
- Poor prognosis in elderly patients with cancer (2003) (3)
- Preventing Obesity and Its Consequences: Highlights of RAND Health Research (2011) (3)
- USE OF COLONY-STIMULATING FACTORS FOR TREATMENT OF NEUTROPENIA AND INFECTIOUS DISEASES (1999) (2)
- The Severe Chronic Neutropenia International Registry - 10 Years of Follow-Up. (2004) (2)
- Changes in the Composition of Canine Respiratory Cells Obtained by Bronchial Lavage following Irradiation or Drug Immunosuppression (1976) (2)
- Neutrophil Elastase Mutations and the Risk of Leukemia In Patients with Cyclic and Congenital Neutropenia. (2010) (2)
- The Influence of Colony-Stimulating Factors on Neutrophil Production, Distribution, and Function (1999) (2)
- Extended Genetic Testing in Severe Congenital Neutropenia May Identify Mutations That Inform Therapy (2018) (2)
- Updated ASCO recommendations for the use of white blood cell growth factors. (2006) (2)
- A Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients. (2005) (2)
- ACP medicine : a publication of the American College of Physicians (2007) (2)
- Myelodysplasia, Leukemia, Lymphoid Malignancies, and Other Cancers in Patients with Severe Chronic Neutropenia (2018) (2)
- Tracers for tracing neutrophils. (2016) (2)
- Factors associated with reductions in chemotherapy dose intensity: Impact of clinical, sociodemographic and practice setting (2007) (2)
- A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis (2022) (2)
- Understanding, Treating and Avoiding Hematological Disease: Better Medicine Through Mathematics? (2014) (2)
- Current management of chemotherapy-induced neutropenia (2003) (2)
- LYMPHADENOPATHY AND LYMPHOPROLIFERATIVE DISORDERS (1993) (2)
- Advances in the use of colony-stimulating factors for chemotherapy-induced neutropenia. (2005) (2)
- Overall Survival of Lymphoma Patients In Randomized Controlled Trials Comparing Primary G-CSF Chemotherapy Support to Control. (2010) (2)
- Chemotherapy-induced febrile neutropenia (FN) and FN prevention strategies in cancer care in the U.S. Veterans Health Administration (VHA). (2013) (2)
- Febrile neutropenia and reduced dose intensity in patients with aggressive non-Hodgkin's lymphoma (NHL) treated with CHOP and CNOP. (2004) (2)
- Shwachman-Diamond Syndrome: Development of a North American Registry to Assess Long-Term Outcomes, Risk of Leukemia and Other Complications. (2009) (2)
- Prospective validation of a risk model for first cycle neutropenic complications in early-stage breast cancer patients receiving adjuvant chemotherapy (2006) (2)
- Gene Expression Profiles for Normal Human Bone Marrow-Derived CD34+ Stem Cells and CD34−/CD33+ Myeloid-Committed Progenitor Cells in Response to Daily Granulocyte-Colony-Stimulating Factor (G-CSF) Treatment. (2004) (2)
- Small Molecule Inhibitor of Neutrophil Elastase and Severe Congenital Neutropenia. (2009) (2)
- Community donors vs. related donors for granulocyte transfusion therapy in hematopoietic transplantations (2000) (2)
- Neutrophil transfusion effect of collection method and of storage on blood kinetics (1976) (2)
- Evaluation of treatment-related acute myeloid leukemia or myelodysplastic syndrome risk following standard chemotherapy versus dose-intensified chemotherapy plus granulocyte colony-stimulating factor. (2009) (2)
- Congenital and Acquired Chronic Neutropenias: Challenges, Perspectives and Implementation of the EuNet-INNOCHRON Action (2020) (2)
- Reduced Relative Dose Intensity (RDI) in Patients with Aggressive Non-Hodgkin’s Lymphoma (NHL). (2004) (2)
- Aetiocholanolone and prednisolone therapy in patients with severe bone-marrow failure. (1977) (2)
- Squatter Sam and Professionalism (2007) (2)
- Intersections of hematology, immunology, dermatology and infectious diseases. (2015) (2)
- The Use of the Colony‐Stimulating Factors for the Prevention and Treatment of Infections: 321 (1997) (2)
- TCIRG1 Associated Congenital Neutropenia (2013) (1)
- The Association of Mutations in RUNX1 and CSF3R with the Development of Leukemia in Severe Congenital Neutropenia: A unique pathway in leukemogenesis (2013) (1)
- Editorial for myeloid biology 2017. (2017) (1)
- Hospitalization with febrile neutropenia in colorectal cancer patients (2004) (1)
- Knock-Down of TAZ Gene Expression: A Model of Barth Syndrome with Accelerated Apoptosis of Myeloid Progenitor Cells Improved upon Treatment with Caspase-Specific Inhibitor (2008) (1)
- Repeated lentivirus-mediated granulocyte colony-stimulating factor administration to treat canine cyclic neutropenia. (2012) (1)
- Comparison of the Veterans Affairs Oncology Registry and the SEER Cancer Registry among patients with lung cancer. (2010) (1)
- Hematopoietic growth factors (1998) (1)
- The benefits of haematopoietic growth factors in the management of gynaecological oncology. (2004) (1)
- Cyclic Neutropenia, Congenital and Idiopathic Neutropenia (2017) (1)
- Cloning and Sequencing of the Canine Neutrophil Elastase cDNA (2002) (1)
- Colony-Stimulating Factors for Prevention and Treatment of Neutropenia and Infectious Diseases (2013) (1)
- Effect of alternate day prednisone therapy on human lymphocyte subpopulations (1974) (1)
- Editorial: myeloid biology issue 2018. (2018) (1)
- Experimental pneumonia due to Pseudomonas in dogs (1974) (1)
- Neutropenia In Glycogen Storage Disease 1b (GSD1b) (2011) (1)
- A Prospective Risk Model for Neutropenic Complications in Patients with Malignant Lymphoma. (2005) (1)
- Small Molecule Inhibitor of Neutrophil Elastase Restores Impaired Production of Human Myeloid Cells Observed in Severe Congenital Neutropenia. (2007) (1)
- Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients (2022) (1)
- Canine cyclic hematopoiesis (CH) (1979) (1)
- Accumulation of Specific Somatic Leukemia-Associated Mutations in Congenital Neutropenia Precedes Malignant Transformation - New Preconditions for Treatment Decisions (2022) (1)
- Editorial: Serine proteases, serpins, and neutropenia (2011) (1)
- Molecular Studies of Neutropenia in Barth Syndrome. (2007) (1)
- IMPROVED SURVIVAL FROM GRANULOCYTE-COLONY STIMULATING FACTOR THERAPY FOR CONGENITAL NEUTROPENIA UNMASKS PREDISPOSITION TO MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA (1999) (1)
- Febrile neutropenia and reduced dose intensity in patients with aggressive non-Hodgkin's lymphoma (NHL) treated with CHOP and CNOP (2004) (1)
- Managing infections in immunosuppressed patients. (1978) (1)
- A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices (2022) (1)
- CRISPR Mediated ELANE Single-Allele Knock-out Restores Proliferation and Myeloid Differentiation of Neutropenia Patient Derived BM HSCs (2020) (1)
- Alpha Omega Alpha: encouraging excellence in medicine for more than a century. (2002) (1)
- President's Address: Physicians and the Pharmaceutical Industry. (2017) (1)
- Mutant allele knockout with novel CRISPR nuclease promotes myelopoiesis in ELANE neutropenia (2022) (1)
- Update on the management of neutropenia. (2006) (1)
- Hematopoietic Growth Factors (Cytokines) (2009) (1)
- Hospitalization with febrile neutropenia in colorectal cancer patients. (2004) (1)
- THE INTERNATIONAL REGISTRY ON SEVERE CHRONIC NEUTROPENIA (SCNIR) (1999) (1)
- Prospective Validation of a Predictive Model for Early Anemia in Patients Receiving Cancer Chemotherapy. (2006) (1)
- Preventing Obesity and Its Consequences (2011) (1)
- The biology and clinical applications of erythropoietin and the colony-stimulating factors. (1995) (1)
- Heterozygous Mutations of Clpb As a Newly Identified and Frequent Cause of Severe Congenital Neutropenia (2019) (1)
- Mutant CXCR4-Induced Aberrant Retention and Apoptosis of Hematopoietic Cells in Myelokathexis and Normalization of Cell Survival and Mobilization with Specific Inhibitors. (2009) (1)
- Barth Syndrome and Severe Chronic Neutropenia. (2010) (1)
- Peg-Filgrastim for the Treatment of Severe Chronic Neutropenia (2016) (1)
- Novel mutations in g-csf receptor implicated in pathogenesis of acute myelogenous leukemia in severe congenital neutropenia (2000) (1)
- Unique Evidence for Autosomal Dominant Inheritance of Severe Congenital Neutropenia. (2004) (1)
- Bone marrow grafting in cyclic neutropenia in dogs (1976) (1)
- Achieving a high-performance health care system: policies and positions of the American College of Physicians. (2008) (1)
- 30 A risk model for first cycle neutropenic events in older cancer patients receiving systemic chemotherapy (2006) (1)
- Twenty years of the colony-stimulating factors. (2012) (1)
- Incidence of SCN-Assoicated Gene Mutations in Severe Congenital Neutropenia Patients in North America (2008) (1)
- Bone Density Measurements in Patients with Severe Chronic Neutropenia On Long-Term G-CSF Therapy. (2009) (1)
- Family Studies of Whim Syndrome (2019) (1)
- Do G-CSF schedules make a difference? (2012) (0)
- CRISPR/Cas9 Mediated ELANE Knock-out Restores Survival and Granulocytic Differentiation of HL60 Cells Expressing Mutant Neutrophil Elastase: Is Neutrophil Elastase a Dispensible Granulocyte Protease? (2019) (0)
- Severe chronic idiopathic neutropenia in adults : Long-term follow-up of 358 patients (2003) (0)
- TCIRG1 Mutations As a Cause for Chronic Neutropenia (2016) (0)
- Results of the ABIM examination (1994) (0)
- P-688 Patterns of care and risk of chemotherapy-induced neutropenia and anemia in patients with lung cancer: Preliminary results from a prospective registry for risk model development (2003) (0)
- O-7 Cost and mortality associated with febrile neutropenia in lung cancer patients (2003) (0)
- Mavorixafor for Patients with Chronic Neutropenic Disorders: Results from a Phase 1b, Open-Label, Multicenter Study (2022) (0)
- PB1938: 4WHIM: EVALUATING MAVORIXAFOR, AN ORAL CXCR4 ANTAGONIST, IN PATIENTS WITH WHIM SYNDROME VIA A GLOBAL PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION (2022) (0)
- The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action (2023) (0)
- arising in the setting of severe congenital neutropenia Distinct patterns of mutations occurring in de novo AML versus AML (2013) (0)
- CYTOKINES IN THE TREATMENT OF INFECTION (1997) (0)
- Barth Syndrome: An Under-Recognized Cause of Chronic Neutropenia (2015) (0)
- Defining the role and responsibilities of the general internist (1991) (0)
- Training in outpatient care (1991) (0)
- Severe Chronic Neutropenia in the Large Granular Lymphocyte Syndrome: Outcomes in Response to Granulocyte Colony Stimulating Factor (G-CSF) and Immunosuppressive Therapies (2019) (0)
- Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia Studies investigating combination therapy of a beta-lactam with an aminoglycoside in animals with neutropenia (2008) (0)
- The colony stimulating factors for the management of chemotherapy-induced neutropenia (2005) (0)
- Oral Administration of Mavorixafor, a CXCR4 Antagonist, Increases Peripheral White Blood Cell Counts across Different Disease States (2021) (0)
- Mutations in the Gene for Neutrophil Elastase in Severe Congenital Neutropenia Are Heterozygous and of Male Origin. (2004) (0)
- Granulocyte Transfusions (2000) (0)
- precursors in neutrophil bcl-x by accelerated apoptosis and defective expression of Myelokathexis , a congenital disorder of severe neutropenia characterized (1999) (0)
- What is WHIM syndrome? IVIg in ITP: no role for cytokines? (2006) (0)
- Neutropenia Is an Under-Recognized Finding in Pediatric Primary Immunodeficiency Diseases: An Analysis of the United States Immunodeficiency Network Registry (2018) (0)
- PF343 CRISPR/CAS9 MEDIATED ELANE KNOCKOUT ENABLES NEUTROPHILIC MATURATION OF HSPCS AND IPSCS OF SEVERE CONGENITAL NEUTROPENIA PATIENTS (2019) (0)
- Mavorixafor, an Oral CXCR4 Antagonist, for Treatment of Patients with WHIM Syndrome: Results from the Long-Term Extension of the Open-Label Phase 2 Study (2021) (0)
- A case report of cyclic thrombocytopenia with statistically significant neutrophil oscillations (2017) (0)
- Table 1. [Summary of Molecular Genetic Testing Used in ELANE-Related Neutropenia]. (2011) (0)
- Novel TCIRG1 Mutations Causing Congenital Neutropenia (2022) (0)
- Neutrophil elastase and neutropenia (2004) (0)
- Statement for the Record of the Hearing of the House Ways and Means Committee Subcommittee on Health on “ Strategies to Increase Research and Information on Comparative (2007) (0)
- Improving care of patients with immunodeficiency diseases. (2013) (0)
- Neutropenia in premature infants Definitions and pathophysiology (2017) (0)
- severe congenital neutropenia receiving long-term G-CSF therapy The incidence of leukemia and mortality from sepsis in patients with (2013) (0)
- Stem cell differentiation in tumor induced neutrophilia. Abstr. (1981) (0)
- Predicting the Risk of Neutropenic Complications and Reduced Dose Intensity in Patients with Malignant Lymphoma: Results from a Prospective Study. (2004) (0)
- Cyclic Neutropenia Is Not Associated with Transformation to MDS and AML. (2007) (0)
- The Experience of the Cooperation in Science and Technology European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias (COST EuNet-INNOCHRON) Action and the Sweden Experience in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Era (2021) (0)
- Improved Survival From Granulocyte-Colony Stimulating Factor Therapy for Congenital Neutropenia Unmasks Predisposition to Myelodysplasia and Acute Myeloid Leukemia (1999) (0)
- Hematopoietic growth factors. Commentary. (1994) (0)
- Editorial: Update in myeloid biology. (2019) (0)
- delivery Treatment of canine cyclic neutropenia by lentivirus-mediated G-CSF (2013) (0)
- Genotype-Phenotype Associations in Patients with Severe Congenital Neutropenia. (2006) (0)
- Factitious Fever and Self-Induced Infection (2020) (0)
- Update on hematopoietic growth factors-2002 (2002) (0)
- Congenital Neutropenia (2020) (0)
- ELANE Mutations in Cyclic and Congenital Neutropenia: Genotype-Phenotype Relationships, (2011) (0)
- Beginning and finishing (1994) (0)
- rHUG-CSF for the treatment of severe chronic neutropenia (2012) (0)
- Spectrum of Pathogenic Genetic Variants in a Large Cohort of North American Congenital and Cyclic Neutropenia Patients: A Report from the Severe Chronic Neutropenia International Registry (2021) (0)
- Includes: Cyclic Neutropenia, Severe Congenital Neutropenia (2011) (0)
- PS01.76: Impact of Chemotherapy Intensity on Progression and Survival in Metastatic Non–Small Cell Lung Cancer: A Systematic Review: Topic: Medical Oncology (2016) (0)
- Assessment of Hematologic and Non-Hematologic Toxicity in Older Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Registry. (2004) (0)
- James W. Haviland: 1911–2007. (2009) (0)
- Neutrophils: Function and Role in Sepsis Syndrome Neutrophils: Fun ction and Role in Sepsis Syn drome (1998) (0)
- Accelerated Apoptosis and Aberrant Retention of Bone Marrow Cells in Myelokathexis Are Two Independent Pathways Triggered by Mutant CXCR4 and Normalized upon Treatment with Specific Inhibitors. (2007) (0)
- Comprar Hematopoietic Growth Factors In Oncology | Gary H. Lyman | 9781441970725 | Springer (2010) (0)
- Small Molecule Inhibitor of Neutrophil Elastase Normalizes Myeloid Differentiation and Improves Impaired Cell Survival Triggered by Elastase Mutations In Patients with Severe Congenital Neutropenia and Acute Myeloid Leukemia (2010) (0)
- JGIM becomes a monthly (2007) (0)
- Granulocyte colony-stimulating factor (G-CSF) administered to normal human volunteers in vivo augments neutrophil host defenses against opportunistic fungal pathogens (1996) (0)
- Social and racial disparities in the use of non-standard breast cancer adjuvant chemotherapy regimens. (2006) (0)
- Department of Medicine, University of Washington School of Medicine, Seattle, Wash. (1976) (0)
- Safe and Efficient Engraftment of CRISPR-Based ELANE Mono-Allelic Knocked out HSCs in Mice: Evidence for a Novel Treatment for ELANE Neutropenia (2021) (0)
- Supplying neutrophils from the bone marrow to the tissues (2006) (0)
- Current patterns of chemotherapy and supportive care for early-stage breast cancer (ESBC). (2012) (0)
- Diversity and Molecular Modeling of Neutrophil Elastase Mutations in Patients with Severe Congenital Neutropenia and Acute Myelogenous Leukemia. (2004) (0)
- Clinical Applications of G-CSF and GM-CSF in the Treatment of Infectious Diseases (2003) (0)
- Long Term Outcomes for Patients with Cyclic Neutropenia Treated with Granulocyte Colony-Stimulating Factor (G-CSF) (2015) (0)
- Determination of Phase 3 Dose for X4P-001 in Patients with WHIM Syndrome (2018) (0)
- The Effects of the Neutrophil Elastase Inhibitors MK0339 and Sivelestat on the Survival, Proliferation and Maturation of iPSC and HL60 Cells Expressing Mutant Neutrophil Elastase (2016) (0)
- Incidence a nd P redictors o f L ow D ose-Intensity i n Adjuvant B reast C ancer C hemotherapy: A N ationwide S tudy o f C ommunity P ractices (2003) (0)
- Mutant CXCR4 Identified in Neutropenic Patients with Myelokathexis Impairs Survival of Human Myeloid Cells. (2005) (0)
- CRISPR/Cas9 Knock-in HL60 Cells Closely Simulate Cellular and Functional Abnormalities of ELANE associated Neutropenia; Phenotype Rescue with MK-0339 Neutrophil Elastase Inhibitor (2018) (0)
- Autosomal dominant cyclic hematopoiesis: Genetics, phenotype, and natural history (1994) (0)
- 459. Long-Term Treatment of Canine Cyclic Neutropenia by G-CSF-Lentivirus (2005) (0)
- Problem-Oriented Medical Diagnosis (1976) (0)
- Introduction to Granulocyte Disorders (2013) (0)
- 53P Incidence of febrile neutropenia (FN), adherence and compliance to granulocyte colony-stimulating factor (G-CSF) on-body injector (OBI) versus other FN prophylaxis in patients receiving myelosuppressive chemotherapy: Subgroup analysis in breast cancer patients (2021) (0)
- University of Washington School of Medicine. (1984) (0)
- Asthma, socioeconomic status, and health care reform (1994) (0)
- Neutropenia and Its Complications (2008) (0)
- The Cellular and Molecular Mechanisms of Neutropenia in Barth Syndrome (2011) (0)
- The risk of leukemia in genetic subgroups of congenital neutropenia (2010) (0)
- Granulocytic Precursors from Patients with ELA2-Mutant Severe Congenital Neutropenia Display a Transcriptional Profile Consistent with Activation of the Unfolded Protein Response. (2007) (0)
- Mutation Burden in Hematopoietic Stem Cells Is Not Increased in Congenital Neutropenia (2016) (0)
- Reply to N. Lathia et al (2010) (0)
- The clinical examination revisited (1993) (0)
- New editors forJGIM (2007) (0)
- Distinct Genetic Pathways Define Leukemia Predisposition Versus Adaptive Clonal Hematopoiesis in Shwachman-Diamond Syndrome (2020) (0)
- Dispositif et methodes d'implantation de cellules ayant subi une transduction (1995) (0)
- Predictors of Transformation to Myelodysplasia/Acute Myelogenous Leukemia (MDS/AML) in Severe Congenital Neutropenia (SCN). (2007) (0)
- Validation of a Risk Model for Hospitalized Adult Cancer Patients with Febrile Neutropenia. (2004) (0)
- Global Phase 3, Randomized, Placebo-Controlled Trial with Open-Label Extension Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients with WHIM Syndrome (4WHIM): Trial Design and Enrollment (2021) (0)
- Report on Patients with Shwachman-Diamond Syndrome with Severe Chronic Neutropenia ♦ 751 (1998) (0)
- The Journal thanks the following consultants who, in addition to the members of the Editorial Board, gave their time to review manuscripts submitted in 1980. (1980) (0)
- When is hospitalization necessary? (1992) (0)
- Recent advances in understanding and clinical applications of the hematopoietic growth factors. (1996) (0)
- Genetic and Phenotypically Heterogeneity of Patients with Congenital Neutropenia. (2005) (0)
- precursors by accelerated apoptosis and defective expression ofbcl-x in neutrophil Myelokathexis, a congenital disorder of severe neutropenia characterized (2013) (0)
- Application of Spectral Density/Periodogram Analysis to Serial Neutrophil Counts to Diagnose Cyclic Neutropenia (2015) (0)
- Interview With David C. Dale, MD: A Pioneer in the Treatment of Congenital Neutropenia and President-Elect of the American College of Physicians. (2007) (0)
- Germline and Somatic Genetic Characterization of Shwachman-Diamond Syndrome (2016) (0)
- cyclic neutropenia Mutations in the gene encoding neutrophil elastase in congenital and (2013) (0)
- What is WHIM syndrome (2007) (0)
- Chemotherapy associated myelosuppression and disease-free and overall survival: A systematic review and evidence summary. (2012) (0)
- THE INTERNATIONAL REGISTRY ON SEVERE CHRONIC NEUTROPENIA (SCNIR) (1999) (0)
- Comprar ACP Medicine | Daniel D. Federman | 9780977222612 | WebMD Professional Publishing (2007) (0)
- Recent progress in understanding the congenital neutropenias. (2010) (0)
- Impact of chemotherapy dose and schedule on progression and survival in metastatic breast cancer: A systematic review. (2014) (0)
- Clinical Features of Shwachman-Diamond Syndrome Patients Lacking Biallelic SBDS Mutation (2011) (0)
- Prednisone dose in alternate day therapy (1975) (0)
- Understanding Neutropenia: The 20 Year Experience of the Severe Chronic Neutropenia International Registry (SCNIR) (2014) (0)
- The Effect of Neutrophil Elastase Inhibitors on in-Vitro Myeloid Differentiation of CD34+ Cells of Patients with ELANE Associated Neutropenia (2022) (0)
- The North American Shwachman-Diamond Syndrome Registry: Genetically Undefined Shwachman-Diamond Syndrome (2015) (0)
- Hematopoietic growth factors and the functions of blood cells. Commentary. (1995) (0)
- Whither thejournal? (2007) (0)
- Neutrophil-Releasing Activity in Plasma of Normal Human Subjects Injected with Etiocholanolone (1977) (0)
- Dispensable Role of Neutrophil Elastase in Survival and Differentiation of Human Myeloid Progenitor Cells (2008) (0)
- The Natural History of Cyclic Neutropenia: Long-Term Prospective Observations and Current Perspectives. (2012) (0)
- New insights into chronic idiopathic neutropenia (2003) (0)
- A multicenter observational study comparing physician-assessed febrile neutropenia (FN) risk and prediction-model severe neutropenia (SN) or FN risk in patients (pts) with nonmyeloid malignancies. (2014) (0)
- Early Studies of AMD3100/Plerixafor in Healthy Volunteers (2012) (0)
- JULIUS KREVANS, MD: 1924 - 2015. (2016) (0)
- A Novel Device Suitable for Home Monitoring of White Blood Cell and Neutrophil Counts (2018) (0)
- Acute Myeloid Leukemia or Myelodysplastic Syndromes and All-Cause Mortality in Randomized Controlled Trials of Cancer Patients Receiving Chemotherapy with or without Granulocyte Colony-Stimulating Factor: A Systematic Review and Meta-Analysis. (2009) (0)
- Comparison of Gene Editing versus a Neutrophil Elastase Inhibitor as Potential Therapies for ELANE Neutropenia (2022) (0)
- Spontaneous Recovery and Normalization of Blood Neutrophil Counts in Young Children with Severe Chronic Neutropenia (2008) (0)
- Prospective cohort study of chemotherapy-associated toxicity and supportive care in oncology practice. (2012) (0)
- Incidence of Secondary Leukemias in Patients With Severe Chronic Neutropenias (1999) (0)
- Risk for Septic Death in Severe Congenital Neutropenia (2008) (0)
- Comprar ACP Medicine | Daniel D. Federman | 9781550093896 | BC Decker (2008) (0)
- Chronic Neutropenia (1979) (0)
- Abstract OT1-05-01: The incidence of febrile neutropenia (FN) for chemotherapy patients receiving pegfilgrastim by an on-body injector (pegfilgrastim OBI) versus other FN prophylaxis strategies (2020) (0)
- The Morphologic Spectrum of Myelokathexis in WHIM Syndrome and Germline CXCR4 Variants: New Insights into Cellular Changes in the Bone Marrow and Peripheral Blood (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David C. Dale?
David C. Dale is affiliated with the following schools:
